"Cell and gene therapies represent a monumental leap forward in medicine, offering the potential to cure previously untreatable diseases. But these life-changing treatments come with eye-watering price tags ... While GLP-1s can offer significant health benefits, their widespread use has led to a surge in pharmacy spending.... Employers are increasingly dissatisfied with their PBMs, citing concerns about rising costs and a lack of transparency."  MORE >>